Jonathan A. Leon Sells 5,282 Shares of Owens & Minor, Inc. (NYSE:OMI) Stock

Owens & Minor, Inc. (NYSE:OMI) CFO Jonathan A. Leon sold 5,282 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Owens & Minor Stock Down 3.4 %

NYSE:OMI opened at $13.19 on Wednesday. Owens & Minor, Inc. has a 1-year low of $11.42 and a 1-year high of $28.35. The firm has a market capitalization of $1.02 billion, a price-to-earnings ratio of -20.29, a PEG ratio of 0.43 and a beta of 0.41. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The business’s fifty day moving average price is $13.71 and its 200 day moving average price is $15.13.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.41 by $0.01. The business had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company posted $0.44 earnings per share. On average, sell-side analysts forecast that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on OMI shares. Barclays reduced their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 5th. Citigroup dropped their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. StockNews.com lowered Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Robert W. Baird cut their target price on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 5th. Finally, JPMorgan Chase & Co. decreased their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research report on Wednesday, August 21st. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $18.50.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds have recently modified their holdings of OMI. Geode Capital Management LLC grew its stake in Owens & Minor by 0.8% in the third quarter. Geode Capital Management LLC now owns 1,711,453 shares of the company’s stock valued at $26,858,000 after purchasing an additional 13,164 shares in the last quarter. Vestcor Inc lifted its holdings in shares of Owens & Minor by 624.2% during the 3rd quarter. Vestcor Inc now owns 41,303 shares of the company’s stock valued at $648,000 after buying an additional 35,600 shares during the last quarter. Barclays PLC grew its stake in shares of Owens & Minor by 354.8% in the 3rd quarter. Barclays PLC now owns 133,702 shares of the company’s stock valued at $2,099,000 after buying an additional 104,305 shares in the last quarter. Jane Street Group LLC grew its stake in shares of Owens & Minor by 126.0% in the 3rd quarter. Jane Street Group LLC now owns 186,280 shares of the company’s stock valued at $2,923,000 after buying an additional 103,871 shares in the last quarter. Finally, Weiss Asset Management LP acquired a new position in Owens & Minor in the third quarter worth approximately $482,000. 98.04% of the stock is owned by institutional investors and hedge funds.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.